NO20032393L - Ekspresjonsanalyse av inhibitor av differensiering av nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft - Google Patents

Ekspresjonsanalyse av inhibitor av differensiering av nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft

Info

Publication number
NO20032393L
NO20032393L NO20032393A NO20032393A NO20032393L NO 20032393 L NO20032393 L NO 20032393L NO 20032393 A NO20032393 A NO 20032393A NO 20032393 A NO20032393 A NO 20032393A NO 20032393 L NO20032393 L NO 20032393L
Authority
NO
Norway
Prior art keywords
differentiation
diagnosis
inhibitor
treatment
nucleic acids
Prior art date
Application number
NO20032393A
Other languages
English (en)
Other versions
NO20032393D0 (no
Inventor
Kimberly A Gillis
Yixian Zhang
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20032393D0 publication Critical patent/NO20032393D0/no
Publication of NO20032393L publication Critical patent/NO20032393L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20032393A 2000-11-28 2003-05-27 Ekspresjonsanalyse av inhibitor av differensiering av nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft NO20032393L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25337400P 2000-11-28 2000-11-28
PCT/US2001/044495 WO2002044417A2 (en) 2000-11-28 2001-11-28 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer

Publications (2)

Publication Number Publication Date
NO20032393D0 NO20032393D0 (no) 2003-05-27
NO20032393L true NO20032393L (no) 2003-07-03

Family

ID=22959998

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032393A NO20032393L (no) 2000-11-28 2003-05-27 Ekspresjonsanalyse av inhibitor av differensiering av nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft

Country Status (14)

Country Link
US (1) US20020182614A1 (no)
EP (1) EP1356107A2 (no)
JP (1) JP2004526424A (no)
AU (1) AU2002239363A1 (no)
BR (1) BR0115689A (no)
CA (1) CA2429721A1 (no)
HU (1) HUP0303890A3 (no)
IL (1) IL155953A0 (no)
MX (1) MXPA03004577A (no)
NO (1) NO20032393L (no)
NZ (1) NZ526706A (no)
PL (1) PL365794A1 (no)
WO (1) WO2002044417A2 (no)
ZA (1) ZA200304997B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2422320A1 (en) * 2000-09-14 2002-03-21 The Regents Of The University Of California Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma
AU2003298689A1 (en) * 2002-11-21 2004-06-18 Wyeth Methods for diagnosing rcc and other solid tumors
US7643943B2 (en) 2003-02-11 2010-01-05 Wyeth Llc Methods for monitoring drug activities in vivo
CA2523798A1 (en) * 2003-04-29 2004-11-11 Wyeth Methods for prognosis and treatment of solid tumors
AU2004273034A1 (en) * 2003-09-05 2005-03-24 Sanofi Pasteur Limited Multi-antigen vectors for melanoma
EP2674435A3 (en) * 2006-03-24 2014-04-30 Phenomenome Discoveries Inc. Biomarkers useful for diagnosing prostate cancer, and methods thereof
WO2022191566A1 (ko) * 2021-03-08 2022-09-15 (주)아큐레시스바이오 췌장암의 진단용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6591396A (en) * 1995-08-01 1997-02-26 Sloan-Kettering Institute For Cancer Research Id as a diagnostic marker in tumor cells
WO1999035244A1 (en) * 1998-01-09 1999-07-15 President And Fellows Of Harvard College IMMORTALIZATION OF PRIMARY HUMAN KERATINOCYTES BY THE HELIX-LOOP-HELIX PROTEIN, Id-1
EP1047793B1 (en) * 1998-01-21 2006-11-15 Dianon Systems, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
CA2422320A1 (en) * 2000-09-14 2002-03-21 The Regents Of The University Of California Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma

Also Published As

Publication number Publication date
HUP0303890A2 (hu) 2004-03-01
IL155953A0 (en) 2003-12-23
WO2002044417A2 (en) 2002-06-06
NZ526706A (en) 2005-03-24
CA2429721A1 (en) 2002-06-06
AU2002239363A1 (en) 2002-06-11
JP2004526424A (ja) 2004-09-02
US20020182614A1 (en) 2002-12-05
MXPA03004577A (es) 2003-09-04
WO2002044417A3 (en) 2003-07-24
EP1356107A2 (en) 2003-10-29
HUP0303890A3 (en) 2006-03-28
BR0115689A (pt) 2004-02-10
WO2002044417A9 (en) 2003-11-20
ZA200304997B (en) 2004-09-27
NO20032393D0 (no) 2003-05-27
PL365794A1 (en) 2005-01-10

Similar Documents

Publication Publication Date Title
NO20032395L (no) Ekspresjonsanalyse av FKBP-nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft
NO20034437D0 (no) Gangliosid-assosierte rekombinante antistoffer og anvendelse derav ved diagnostikk og behandling av tumorer
AU2002318112B2 (en) Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
SI1576170T1 (sl) Nukleinske kisline in ustrezni proteini imenovani 191P4D12(B) uporabni pri zdravljenju in odkrivanju raka
EP1622571A4 (en) NUCLEIC ACIDS AND CORRESPONDING PROTEINS CURED 109P1D4 USEFUL IN THE TREATMENT AND DETECTION OF CANCER
AU6502199A (en) Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
DE60213890D1 (de) Reaktiver Sondenchip und Fluoreszenz-Detektionssystem
NO20032393D0 (no) Ekspresjonsanalyse av inhibitor av differensiering av nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft
EP1372719A4 (en) NUCLEIC ACID AND CORRESPONDING PROTEIN WITH THE NAME 125P5C8 FOR THE TREATMENT AND DETECTION OF CANCER
EP1590437A4 (en) NUCLEIC ACIDS SUITABLE FOR THE TREATMENT AND DETECTION OF CANCER AND CORRESPONDING PROTEINS NAMED 254P1D6B
NO20032391D0 (no) Ekspresjonsanalyse av KIAA-nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft
NO20032394L (no) Ekspresjonsanalyse av SMARC-nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft
NO20020207D0 (no) Biologiske materialer og fremgangsmåter som er nyttige ved diagnostisering og behandling av sykdom
EP1539805A4 (en) NUCLEIC ACIDS AND CORRESPONDING PROTEINS SAID 101P3A11 OR PHOR-1 FOR THE TREATMENT AND DETECTION OF CANCERS
DE50108075D1 (de) Anordnung zur visuellen und quantitativen 3-D-Untersuchung von Proben
HK1057237A (en) Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
HK1057907A (en) Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
HK1055997A (en) Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
GB9917491D0 (en) Biological materials and methods useful in the diagnosis and treastment of diseases
GB9917878D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
DE60035077D1 (de) In Tumoren vervielfältigte Gensequenzen und deren diagnostische Verwendungen
ITNA20000012V0 (it) Macchina di analisi corporea utilizzante misurazione impedenziometrica e ultrasonica.
GB0205963D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB9824091D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB0113011D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases